A detailed history of Artisan Partners Limited Partnership transactions in Glaukos Corp stock. As of the latest transaction made, Artisan Partners Limited Partnership holds 795,246 shares of GKOS stock, worth $120 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
795,246
Previous 1,027,545 22.61%
Holding current value
$120 Million
Previous $122 Million 14.81%
% of portfolio
0.16%
Previous 0.19%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$113.62 - $135.39 $26.4 Million - $31.5 Million
-232,299 Reduced 22.61%
795,246 $104 Million
Q2 2024

Aug 12, 2024

SELL
$89.48 - $118.35 $17.5 Million - $23.1 Million
-195,371 Reduced 15.98%
1,027,545 $122 Million
Q4 2023

Feb 12, 2024

SELL
$59.53 - $85.11 $7.24 Million - $10.4 Million
-121,665 Reduced 9.05%
1,222,916 $97.2 Million
Q3 2023

Nov 09, 2023

SELL
$69.23 - $79.09 $35.6 Million - $40.6 Million
-513,711 Reduced 27.64%
1,344,581 $101 Million
Q2 2023

Aug 10, 2023

SELL
$45.44 - $71.21 $761,801 - $1.19 Million
-16,765 Reduced 0.89%
1,858,292 $132 Million
Q1 2023

May 11, 2023

SELL
$43.88 - $52.48 $1.29 Million - $1.55 Million
-29,512 Reduced 1.55%
1,875,057 $93.9 Million
Q4 2022

Feb 10, 2023

SELL
$40.82 - $57.75 $2.51 Million - $3.55 Million
-61,416 Reduced 3.12%
1,904,569 $83.2 Million
Q3 2022

Nov 10, 2022

BUY
$46.84 - $58.49 $176,118 - $219,922
3,760 Added 0.19%
1,965,985 $105 Million
Q2 2022

Aug 12, 2022

SELL
$34.86 - $63.77 $282,993 - $517,684
-8,118 Reduced 0.41%
1,962,225 $89.1 Million
Q1 2022

May 13, 2022

SELL
$44.33 - $57.82 $583,826 - $761,489
-13,170 Reduced 0.66%
1,970,343 $114 Million
Q4 2021

Feb 11, 2022

BUY
$40.27 - $56.99 $15 Million - $21.2 Million
372,024 Added 23.09%
1,983,513 $88.1 Million
Q3 2021

Nov 12, 2021

SELL
$47.43 - $84.23 $22.7 Million - $40.2 Million
-477,598 Reduced 22.86%
1,611,489 $77.6 Million
Q2 2021

Aug 12, 2021

SELL
$73.06 - $97.7 $16.4 Million - $22 Million
-224,867 Reduced 9.72%
2,089,087 $177 Million
Q1 2021

May 11, 2021

SELL
$70.43 - $97.42 $3.62 Million - $5.01 Million
-51,436 Reduced 2.17%
2,313,954 $194 Million
Q4 2020

Feb 10, 2021

BUY
$48.9 - $75.26 $15.4 Million - $23.7 Million
314,470 Added 15.33%
2,365,390 $178 Million
Q3 2020

Nov 12, 2020

BUY
$37.23 - $50.97 $14.9 Million - $20.4 Million
399,439 Added 24.19%
2,050,920 $102 Million
Q2 2020

Aug 12, 2020

BUY
$28.78 - $46.83 $12.9 Million - $21 Million
448,699 Added 37.31%
1,651,481 $63.5 Million
Q1 2020

May 12, 2020

SELL
$25.53 - $70.14 $69,620 - $191,271
-2,727 Reduced 0.23%
1,202,782 $37.1 Million
Q4 2019

Feb 12, 2020

BUY
$54.18 - $65.64 $6.77 Million - $8.2 Million
124,963 Added 11.56%
1,205,509 $65.7 Million
Q3 2019

Nov 12, 2019

BUY
$58.58 - $83.91 $12.3 Million - $17.6 Million
210,021 Added 24.13%
1,080,546 $67.5 Million
Q2 2019

Aug 09, 2019

BUY
$63.59 - $78.71 $2.08 Million - $2.58 Million
32,728 Added 3.91%
870,525 $65.6 Million
Q1 2019

May 10, 2019

BUY
$50.75 - $80.54 $356,721 - $566,115
7,029 Added 0.85%
837,797 $65.7 Million
Q4 2018

Feb 12, 2019

BUY
$52.18 - $67.93 $2.55 Million - $3.31 Million
48,788 Added 6.24%
830,768 $46.7 Million
Q3 2018

Nov 13, 2018

BUY
$38.13 - $68.37 $13.6 Million - $24.3 Million
355,734 Added 83.46%
781,980 $50.8 Million
Q2 2018

Aug 10, 2018

BUY
$27.62 - $44.51 $78,578 - $126,630
2,845 Added 0.67%
426,246 $17.3 Million
Q1 2018

May 10, 2018

SELL
$26.05 - $34.5 $748,781 - $991,668
-28,744 Reduced 6.36%
423,401 $13.1 Million
Q4 2017

Feb 12, 2018

SELL
$24.5 - $36.01 $128,331 - $188,620
-5,238 Reduced 1.15%
452,145 $11.6 Million
Q3 2017

Nov 13, 2017

BUY
$31.26 - $42.03 $14.3 Million - $19.2 Million
457,383
457,383 $15.1 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.18B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Artisan Partners Limited Partnership Portfolio

Follow Artisan Partners Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artisan Partners Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Artisan Partners Limited Partnership with notifications on news.